Promising phase II data on cabozantinib in patients with prostate cancer and soft tissue disease Feb. 22, 2011
Initial doses of TRC-105 are tolerated in patients with castration-resistant prostate cancer Feb. 22, 2011
Creatine kinase levels predict hemorrhagic transformation in patients receiving alteplase for stroke Feb. 21, 2011
RSS